Public Release:  Did the end of smallpox vaccination cause the explosive spread of HIV?

BioMed Central

Vaccinia immunization, as given to prevent the spread of smallpox, produces a five-fold reduction in HIV replication in the laboratory. Researchers writing in the open access journal BMC Immunology suggest that the end of smallpox vaccination in the mid-20th century may have caused a loss of protection that contributed to the rapid contemporary spread of HIV.

Raymond Weinstein, a family doctor turned laboratory scientist at George Mason University, Manassas, Virginia, USA, worked with a team of researchers from George Washington University and UCLA. The researchers looked at the ability of white blood cells taken from people recently immunised with vaccinia to support HIV replication compared to unvaccinated controls. They found significantly lower viral replication in blood cells from vaccinated individuals. Weinstein said, "There have been several proposed explanations for the rapid spread of HIV in Africa, including wars, the reuse of unsterilized needles and the contamination of early batches of polio vaccine. However, all of these have been either disproved or do not sufficiently explain the behavior of the HIV pandemic. Our finding that prior immunization with vaccinia virus may provide an individual with some degree of protection to subsequent HIV infection suggests that the withdrawal of such vaccination may be a partial explanation".

Smallpox immunization was gradually withdrawn from the 1950s to the 1970s following the worldwide eradication of the disease, and HIV has been spreading exponentially since approximately the same time period. Weinstein and his colleagues propose that vaccination may confer protection against HIV by producing long term alterations in the immune system, possibly including the expression of a certain receptor, CCR5, on the surface of a person's white blood cells which is exploited by both viruses. Speaking about the results, Weinstein said, "While these results are very interesting and hopefully may lead to a new weapon against the HIV pandemic, they are very preliminary and it is far too soon to recommend the general use of vaccinia immunization for fighting HIV".

###

Notes to Editors

  1. Significantly Reduced CCR5-tropic HIV-1 Replication in vitro in Cells from Subjects Previously Immunized with Vaccinia Virus
    Raymond S Weinstein, Michael M Weinstein, Kenneth Alibek, Michael I Bukrinsky and Brichacek Beda
    BMC Immunology (in press)

    During embargo, article available here: http://www.biomedcentral.com/imedia/1059058911315787_article.pdf?random=246213

    After the embargo, article available at the journal website: http://www.biomedcentral.com/bmcimmunol/

    Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.

    Article citation and URL available on request at press@biomedcentral.com on the day of publication.

  2. BMC Immunology is an open access journal publishing original peer-reviewed research articles in molecular, cellular, tissue-level, organismal, functional, and developmental aspects of the immune system. BMC Immunology (ISSN 1471-2172) is indexed/tracked/covered by PubMed, MEDLINE, BIOSIS, CAS, EMBASE, Scopus, CABI, Thomson Reuters (ISI) and Google Scholar.

  3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.